Screening for Arteriopathy in General Medicine: a Preliminary Feasibility Study (DAG)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The secondary objectives of this study are:
A. To assess the prevalence of Abdominal Aortic Aneurysm (AAA) detected by ultrasound measurement of the anterior and posterior longitudinal outer diameter of the sub-renal abdominal aorta in a high cardiovascular risk population consulting with general practitioners (defined according to recommendations stated by the French Society of Vascular Medicine).
B. To assess the prevalence of Peripheral Obliterative Arteriopathy of the Legs (POAL) by measuring the Systolic Pressure Index (SPI) at the toe (ratio of arterial pressure in upper limbs versus lower limbs). Measures are made by a general practitioner in the same population.
C. To assess the quality and interpretability of ultrasound recordings and ultrasound acquistion failure rate. These second measures are made by an expert in vascular medecine. This evaluation with use a 3-level scale:
- appropriate image was not obtained or not recognized expert - uninterpretable
- poor image quality - interpretable
- image of good or very good quality - interpretable
D. To calculate the impact of risk cofactors such as hypertension , smoking, age and family history among patients diagnosed with AAA.
E. Evaluation of general practitioner training from a qualitative and quantitative point of view after 4 h of training organized by Dr. Bobbià .
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Nîmes Cedex 9, Frankrike, 30029
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
Nîmes cedex 2, Frankrike, 30908
- Centre Médico Sportif
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient falls into one of the following 4 groups as defined by the French Society of Vascular Medecin (2006):
- (1) Men and women 60-75 years of age who are active smokers or ex-smokers
- (2) Men over 75 years of age
- (3) Women over 75 years of age who smoke and who have known hypertension
- (4) Men and women over 50 years of age with a family history of aneurysm of the abdominal aorta
Exclusion Criteria:
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- The subject has an allergy to the gel used for ultrasound examination.
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
The study population
See inclusion/exclusion criteria. Intervention: First ultrasound reading Intervention: Second ultrasound interpretation |
First ultrasound reading of the sub-renal abdominal aorta by a general practitioner.
The untrasound images recorded by general practitioners will be interpreted a second time by an expert in vascular medecine, and evaluated for their image quality.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Largest external antero-posterior diameter of the sub-renal abdominal aorta (mm)
Tidsram: Baseline (day 0)
|
Measures made using both cross-sectional and longitudinal ultrasounds.
|
Baseline (day 0)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
SPI at the toe (mmHg)
Tidsram: baseline (Day 0)
|
baseline (Day 0)
|
|
|
Largest external antero-posterior diameter of the sub-renal abdominal aorta (mm) : second interpretation of echographic material by a second expert
Tidsram: maximum of three months
|
Measures made using both cross-sectional and longitudinal ultrasounds.
|
maximum of three months
|
|
Ultrasound quality as assessed by the second expert
Tidsram: maximum of three months
|
This evaluation with use a 3-level scale:
|
maximum of three months
|
Andra resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Ålder
Tidsram: baslinje (dag 0)
|
baslinje (dag 0)
|
|
Smoker? yes/no
Tidsram: baseline (day 0)
|
baseline (day 0)
|
|
Hypertension? yes/no
Tidsram: baseline (day 0)
|
baseline (day 0)
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- LOCAL/2013/JLLD-01
- 2013-A01583-42 (Annan identifierare: RCB number)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .